Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Pemvidutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altimmune Poised For $1B+ Opportunity As MASH Drug Aces Phase IIb
    Altimmune Poised For $1B+ Opportunity As MASH Drug Aces Phase IIb

    13 Nov 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/altimmune-poised-for-1b-opportunity-as-mash-drug-aces-phase-iib

    BIOSPACE
    13 Nov 2025
    Share Share
    Altimmune Announces Publication of IMPACT Phase 2b Trial Data
    Altimmune Announces Publication of IMPACT Phase 2b Trial Data

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185445/0/en/Altimmune-Announces-Publication-of-IMPACT-Phase-2b-Trial-Data-in-The-Lancet-and-Concurrent-Late-Breaking-Oral-Presentation-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Altimmune Show AI-Based Liver Fibrosis Data From Pemvidutide Ph2b
    Altimmune Show AI-Based Liver Fibrosis Data From Pemvidutide Ph2b

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183618/0/en/Altimmune-Presents-AI-Based-Analysis-of-Liver-Fibrosis-Reduction-from-IMPACT-Phase-2b-Trial-of-Pemvidutide-in-MASH-in-Late-breaking-Poster-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Metavia To Unveil DA-1726 Phase 1 Data At Obesityweek 2025
    Metavia To Unveil DA-1726 Phase 1 Data At Obesityweek 2025

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metavia-to-present-new-phase-1-and-pre-clinical-data-on-da-1726-at-obesityweek-2025-302604527.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Altimmune To Present Phase 2B Pemvidutide Data In MASH At AASLD
    Altimmune To Present Phase 2B Pemvidutide Data In MASH At AASLD

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169260/0/en/Altimmune-to-Present-Phase-2b-IMPACT-Data-on-Pemvidutide-in-MASH-in-Late-Breaking-Oral-Podium-Presentation-and-Late-Breaking-Poster-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Altimmune Names Christophe Arbet-Engels, M.d., Phd CMO
    Altimmune Names Christophe Arbet-Engels, M.d., Phd CMO

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157611/0/en/Altimmune-Appoints-Industry-Veteran-Christophe-Arbet-Engels-M-D-PhD-as-Chief-Medical-Officer-to-Drive-Next-Phase-of-Clinical-Development-of-Pemvidutide.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share